18-Methylaminocoronaridine

18-Methylaminocoronaridine
Identifiers
CAS Number	1807784-35-5 [EPA];
PubChem CID	71308131;
ChemSpider	24721797 ;
CompTox Dashboard (EPA)	DTXSID301046165 ;
Chemical and physical data
Formula	C22H29N3O2
Molar mass	367.493 gÂ·molâ1
3D model (JSmol)	Interactive image;
	SMILES c4cccc1c4[nH]c3c1CCN2CC(C5)CC3(C(=O)OC)C2C5CCNC;
	InChI InChI=1S/C22H29N3O2/c1-23-9-7-15-11-14-12-22(21(26)27-2)19-17(8-10-25(13-14)20(15)22)16-5-3-4-6-18(16)24-19/h3-6,14-15,20,23-24H,7-13H2,1-2H3/t14-,15+,20+,22-/m1/s1 ; Key:YKMOJVPLIUXEIP-SVBQBFEESA-N ;
	(verify)

(â)-18-Methylaminocoronaridine (18-MAC) is a second generation synthetic derivative of ibogaine developed by the research team led by the pharmacologist Stanley D. Glick from the Albany Medical College and the chemist Martin E. Kuehne from the University of Vermont.^[1]^[2]